Literature DB >> 28802827

The novel heme-dependent inducible protein, SRRD regulates heme biosynthesis and circadian rhythms.

Yuka Adachi1, Mana Umeda1, Asako Kawazoe1, Tetsuya Sato2, Yasuyuki Ohkawa3, Sakihito Kitajima1, Shingo Izawa1, Ikuko Sagami4, Shigeru Taketani5.   

Abstract

Heme plays a role in the regulation of the expression of genes related to circadian rhythms and heme metabolism. In order to identify new heme-regulated proteins, an RNA sequence analysis using mouse NIH3T3 cells treated without or with 5-aminolevulinic acid (ALA) was performed. Among the changes observed in the levels of various mRNAs including heme oxygenase-1 (HO-1) and ALA synthase-1 (ALAS1), a mouse homologue of the plant circadian-regulating protein SRR1, SRR1 domain containing (SRRD) was induced by the ALA treatment. The expression of SRRD was dependent on heme biosynthesis, and increased the production of heme. SRRD was expressed under circadian rhythms, and influenced the expression of clock genes including PER2, BMAL1, and CLOCK. The knockout of SRRD arrested the growth of cells, indicating that SRRD plays roles in heme-regulated circadian rhythms and cell proliferation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALA; Circadian rhythms; Heme biosynthesis; Knockout; PER2; SRRD

Mesh:

Substances:

Year:  2017        PMID: 28802827     DOI: 10.1016/j.abb.2017.08.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  2 in total

1.  Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells.

Authors:  Elizabeth A Sweeny; Anuradha Bharara Singh; Ritu Chakravarti; Osiris Martinez-Guzman; Arushi Saini; Mohammad Mahfuzul Haque; Greer Garee; Pablo D Dans; Luciana Hannibal; Amit R Reddi; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2018-07-16       Impact factor: 5.157

Review 2.  Targeting REV-ERBα for therapeutic purposes: promises and challenges.

Authors:  Shuai Wang; Feng Li; Yanke Lin; Baojian Wu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.